Drug Discovery and Development Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510245830

Publication Date:

October 21, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Drug Discovery and Development Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Drug Discovery and Development Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Discovery and Development Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Drug Discovery and Development Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Drug Discovery and Development Services include IQVIA, WuXi AppTec, alvern Panalytical锛圫pectris锛�, Sygnature Discovery, RTI International, Genesis Biotechnology Group, Eurofins DiscoverX and Dalton Pharma Services, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Discovery and Development Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Discovery and Development Services by region & country, by Type, and by Application.
The Drug Discovery and Development Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery and Development Services.
麻豆原创 Segmentation
By Company
IQVIA
WuXi AppTec
alvern Panalytical锛圫pectris锛�
Sygnature Discovery
RTI International
Genesis Biotechnology Group
Eurofins DiscoverX
Dalton Pharma Services
Segment by Type:
Macromolecular Drug
Small Molecule Drug
Segment by Application
Pharmaceutical and Biological Companies
Academic Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Discovery and Development Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug Discovery and Development Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug Discovery and Development Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Drug Discovery and Development Services Product Introduction
1.2 Global Drug Discovery and Development Services 麻豆原创 Size Forecast
1.3 Drug Discovery and Development Services 麻豆原创 Trends & Drivers
1.3.1 Drug Discovery and Development Services Industry Trends
1.3.2 Drug Discovery and Development Services 麻豆原创 Drivers & Opportunity
1.3.3 Drug Discovery and Development Services 麻豆原创 Challenges
1.3.4 Drug Discovery and Development Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Discovery and Development Services Players Revenue Ranking (2023)
2.2 Global Drug Discovery and Development Services Revenue by Company (2019-2024)
2.3 Key Companies Drug Discovery and Development Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug Discovery and Development Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug Discovery and Development Services
2.6 Drug Discovery and Development Services 麻豆原创 Competitive Analysis
2.6.1 Drug Discovery and Development Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug Discovery and Development Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery and Development Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Macromolecular Drug
3.1.2 Small Molecule Drug
3.2 Global Drug Discovery and Development Services Sales Value by Type
3.2.1 Global Drug Discovery and Development Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug Discovery and Development Services Sales Value, by Type (2019-2030)
3.2.3 Global Drug Discovery and Development Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biological Companies
4.1.2 Academic Institution
4.1.3 Others
4.2 Global Drug Discovery and Development Services Sales Value by Application
4.2.1 Global Drug Discovery and Development Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug Discovery and Development Services Sales Value, by Application (2019-2030)
4.2.3 Global Drug Discovery and Development Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug Discovery and Development Services Sales Value by Region
5.1.1 Global Drug Discovery and Development Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug Discovery and Development Services Sales Value by Region (2019-2024)
5.1.3 Global Drug Discovery and Development Services Sales Value by Region (2025-2030)
5.1.4 Global Drug Discovery and Development Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug Discovery and Development Services Sales Value, 2019-2030
5.2.2 North America Drug Discovery and Development Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug Discovery and Development Services Sales Value, 2019-2030
5.3.2 Europe Drug Discovery and Development Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug Discovery and Development Services Sales Value, 2019-2030
5.4.2 Asia Pacific Drug Discovery and Development Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug Discovery and Development Services Sales Value, 2019-2030
5.5.2 South America Drug Discovery and Development Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug Discovery and Development Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug Discovery and Development Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Discovery and Development Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug Discovery and Development Services Sales Value
6.3 United States
6.3.1 United States Drug Discovery and Development Services Sales Value, 2019-2030
6.3.2 United States Drug Discovery and Development Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug Discovery and Development Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Discovery and Development Services Sales Value, 2019-2030
6.4.2 Europe Drug Discovery and Development Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug Discovery and Development Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug Discovery and Development Services Sales Value, 2019-2030
6.5.2 China Drug Discovery and Development Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug Discovery and Development Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug Discovery and Development Services Sales Value, 2019-2030
6.6.2 Japan Drug Discovery and Development Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug Discovery and Development Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug Discovery and Development Services Sales Value, 2019-2030
6.7.2 South Korea Drug Discovery and Development Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug Discovery and Development Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Discovery and Development Services Sales Value, 2019-2030
6.8.2 Southeast Asia Drug Discovery and Development Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug Discovery and Development Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug Discovery and Development Services Sales Value, 2019-2030
6.9.2 India Drug Discovery and Development Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug Discovery and Development Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 IQVIA
7.1.1 IQVIA Profile
7.1.2 IQVIA Main Business
7.1.3 IQVIA Drug Discovery and Development Services Products, Services and Solutions
7.1.4 IQVIA Drug Discovery and Development Services Revenue (US$ Million) & (2019-2024)
7.1.5 IQVIA Recent Developments
7.2 WuXi AppTec
7.2.1 WuXi AppTec Profile
7.2.2 WuXi AppTec Main Business
7.2.3 WuXi AppTec Drug Discovery and Development Services Products, Services and Solutions
7.2.4 WuXi AppTec Drug Discovery and Development Services Revenue (US$ Million) & (2019-2024)
7.2.5 WuXi AppTec Recent Developments
7.3 alvern Panalytical锛圫pectris锛�
7.3.1 alvern Panalytical锛圫pectris锛� Profile
7.3.2 alvern Panalytical锛圫pectris锛� Main Business
7.3.3 alvern Panalytical锛圫pectris锛� Drug Discovery and Development Services Products, Services and Solutions
7.3.4 alvern Panalytical锛圫pectris锛� Drug Discovery and Development Services Revenue (US$ Million) & (2019-2024)
7.3.5 Sygnature Discovery Recent Developments
7.4 Sygnature Discovery
7.4.1 Sygnature Discovery Profile
7.4.2 Sygnature Discovery Main Business
7.4.3 Sygnature Discovery Drug Discovery and Development Services Products, Services and Solutions
7.4.4 Sygnature Discovery Drug Discovery and Development Services Revenue (US$ Million) & (2019-2024)
7.4.5 Sygnature Discovery Recent Developments
7.5 RTI International
7.5.1 RTI International Profile
7.5.2 RTI International Main Business
7.5.3 RTI International Drug Discovery and Development Services Products, Services and Solutions
7.5.4 RTI International Drug Discovery and Development Services Revenue (US$ Million) & (2019-2024)
7.5.5 RTI International Recent Developments
7.6 Genesis Biotechnology Group
7.6.1 Genesis Biotechnology Group Profile
7.6.2 Genesis Biotechnology Group Main Business
7.6.3 Genesis Biotechnology Group Drug Discovery and Development Services Products, Services and Solutions
7.6.4 Genesis Biotechnology Group Drug Discovery and Development Services Revenue (US$ Million) & (2019-2024)
7.6.5 Genesis Biotechnology Group Recent Developments
7.7 Eurofins DiscoverX
7.7.1 Eurofins DiscoverX Profile
7.7.2 Eurofins DiscoverX Main Business
7.7.3 Eurofins DiscoverX Drug Discovery and Development Services Products, Services and Solutions
7.7.4 Eurofins DiscoverX Drug Discovery and Development Services Revenue (US$ Million) & (2019-2024)
7.7.5 Eurofins DiscoverX Recent Developments
7.8 Dalton Pharma Services
7.8.1 Dalton Pharma Services Profile
7.8.2 Dalton Pharma Services Main Business
7.8.3 Dalton Pharma Services Drug Discovery and Development Services Products, Services and Solutions
7.8.4 Dalton Pharma Services Drug Discovery and Development Services Revenue (US$ Million) & (2019-2024)
7.8.5 Dalton Pharma Services Recent Developments
8 Industry Chain Analysis
8.1 Drug Discovery and Development Services Industrial Chain
8.2 Drug Discovery and Development Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Discovery and Development Services Sales Model
8.5.2 Sales Channel
8.5.3 Drug Discovery and Development Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

IQVIA
WuXi AppTec
alvern Panalytical锛圫pectris锛�
Sygnature Discovery
RTI International
Genesis Biotechnology Group
Eurofins DiscoverX
Dalton Pharma Services

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.